APO A-V -1131T → C polymorphism frequency and its association with morbidity in a Brazilian elderly population

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 1, 2006, Pages 32-36

  Chen, Elizabeth S ^a   Cendoroglo, Maysa S ^a   Ramos, Luiz R ^a   Araujo, Lara M Q ^a   Carvalheira, Gianna M G ^a   De Lábio, Roger W ^b   Burbano, Rommel R ^a   Payão, Spencer L M ^b   Smith, Marília De A C ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^c 740 Edifício Leitão da Cunha   (Brazil)

Author keywords

1131T C; Apo A V; Elderly; Morbidity; Polymorphism; SNP3

Indexed keywords

APOLIPOPROTEIN A5; RESTRICTION ENDONUCLEASE;

AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; ASIAN; BRAZIL; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DNA ISOLATION; EUROPEAN AMERICAN; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; ALLELES; APOLIPOPROTEINS; BRAZIL; DISEASE; FEMALE; GENE FREQUENCY; HUMANS; MALE; MORBIDITY; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; THYMIDINE;

EID: 29444453303     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.007     Document Type: Article

References (34)

1. Finch CE, Tanzi RE. Genetics of aging. Science 1997;278:407-11.
2. Souza MF, Filho AM, Malta DC, Duarte EC, Oliveira G, Cordeiro LD. Análise dos dados de mortalidade de 2001. In: Ministério da Saúde. Saúde Brasil 2004 uma análise da situação de saúde, Brasília: Secretaria de Vigilância em Saúde, 2004;137-231.
3. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.
4. Steinberg D, Gotto AM. Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside. J Am Med Assoc 1999;282:2043-50.
5. Olivier M, Wang X, Cole R, Gau B, Kim J, Rubin EM, et al. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 2004;83:912-23.
6. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001;294:169.
7. Hubacek JA, Skodova Z, Adamkova V, Lanska V, Poledne R. The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 2004;65:126-30.
8. Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma GT, Csaszar A, et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 2004;173:109-14.
9. Bi N, Yan SK, Li GP, Yin ZN, Chen BS. A single nucleotide polymorphism -1131T > C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab 2004;83:280-6.
10. Tang Y, Sun P, Guo D, Ferro A, Ji Y, Chen Q, et al. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 2005, in press (Epub ahead of print; DOI 10.1016/j.atherosclerosis.2005.06.026).
11. Pennacchio LA, Rubin EM. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 2003;23:529-34.
12. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 2003;12:2533-9.
13. Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, Kesaniemi YA, et al. APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 2004;45:750-6.
14. Lee KW, Ayyobi AF, Frohlich JJ, Hill JS. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis 2004;176:165-72.
15. Chaaba R, Attia N, Hammami S, Smaoui M, Mahjoub S, Hammami M, et al. Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis 2005;4:1.
16. Ramos LR, Toniolo J, Cendoroglo MS, Garcia JT, Najas MS, Perracini M, et al. Two-year follow-up study of elderly residents in S. Paulo, Brazil: methodology and preliminary results. Rev Saude Publica 1998;32:397-407.
17. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
19. DECODE Study Group. European Diabetes Epidemiology Group Diabetes. Epidemiology: collaborative analysis of diagnostic criteria in Europe. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999;42:647-54.
20. Kyle UG, Genton L, Hans D, Karsegard VL, Michel JP, Slosman DO, et al. Total body mass, fat mass, fat-free mass, and skeletal muscle in older people: cross-sectional differences in 60-year-old persons. J Am Geriatr Soc 2001;49:1633-40.
21. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991;45:13-21.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
23. Bertolucci PH, Brucki SM, Campacci SR, Juliano Y. [The Mini-Mental State Examination in a general population: impact of educational status]. Arq Neuropsiquiatr 1994;52:1-7.
24. Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR. Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 2001;59(Suppl 3A):532-6.
25. Blay SL, Ramos LR, Mari Jde J. Validity of a Brazilian version of the Older Americans Resources and Services (OARS) mental health screening questionnaire. J Am Geriatr Soc 1988;36:687-92.
26. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 1989;79:1554-6.
27. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
28. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002;11:3031-8.
29. Nabika T, Nasreen S, Kobayashi S, Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 2002;165:201-4.
30. Austin MA, Talmud PJ, Farin FM, Nickerson DA, Edwards KL, Leonetti D, et al. Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim Biophys Acta 2004;1688:1-9.
31. Barreto SM, Passos VM, Cardoso AR, Lima-Costa MF. Quantifying the risk of coronary artery disease in a community: the Bambui project. Arq Bras Cardiol 2003;81:556-61.
32. Abrantes MM, Lamounier JA, Colosimo EA. [Overweight and obesity prevalence among children and adolescents from Northeast and Southeast regions of Brazil]. J Pediatr 2002;78:335-40.
33. Lai CQ, Tai ES, Tan CE, Cutter J, Chew SK, Zhu YP, et al. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003;44:2365-73.
34. Jang Y, Kim JY, Kim OY, Lee JE, Cho H, Ordovas JM, et al. The -1131T → C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr 2004;80:832-40.